Diaceutics wins data deal with unnamed pharma firm
1st Apr 2021 16:05
(Sharecast News) - Diaceutics has secured a data licensing agreement with an unnamed global pharmaceutical company to provide Covid-19 testing data insights in the US, it announced on Thursday, enabled by its proprietary diagnostic network 'DXRX'.
Read moreDiaceutics pleased with 2020 performance
11th Jan 2021 16:12
(Sharecast News) - Diaceutics updated the market on its trading in 2020 on Monday, reporting that its revenue and adjusted EBITDA for the year ended 31 December were expected to be around £12.6m, down from £13.4m, and £0.5m, down from £2.2m respectively, with EBITDA breakeven.
Read moreDiaceutics shares rise as it launches new diagnostic development platform
28th Oct 2020 13:48
(Sharecast News) - Diaceutics announced the launch of its 'DXRX - The Diagnostic Network digital platform on Wednesday, which it said was designed to accelerate the development and commercialisation of precision medicine diagnostics using a new operating model.
Read moreDiaceutics wins ?1m pharmaceutical client contract
22nd Jul 2020 09:45
(Sharecast News) - Diagnostic commercialisation company Diaceutics announced a new, "significant" client contract win with an unnamed pharmaceutical company on Wednesday.
Read moreDiaceutics builds on strong Q1, trades in line
8th Jul 2020 08:06
(Sharecast News) - Diagnostic commercialisation company Diaceutics said on Wednesday that it had built on its good start to the financial year, with trading in the first half in line with expectations.
Read moreDiaceutics raising £20.5m ahead of launch of new platform
11th Jun 2020 12:33
(Sharecast News) - Diagnostics commercialisation company Diaceutics has conditionally raised £20.5m before expenses, through a placing of 14,137,931 new shares at 145p each to existing and new investors in two tranches, it announced on Thursday.
Read moreDiaceutics maintains expectations after first quarter
19th May 2020 10:56
(Sharecast News) - Diaceutics said it had made a "good start" to the 2020 financial year on Tuesday, with trading in the first quarter in line with the board's expectations.
Read moreDiaceutics flags serious fall in cancer testing amid Covid-19
29th Apr 2020 09:29
(Sharecast News) - Precision diagnostics commercialisation company Diaceutics announced research results from its Covid-19 oncology tracker on Wednesday, which it said showed the impact of the crisis on cancer testing and diagnosis in the United States.
Read moreDiaceutics beats expectations on revenue and earnings
13th Jan 2020 10:44
(Sharecast News) - Pharmaceutical data analytics and implementation services provider Diaceutics updated the market on its trading for the year ended 31 December on Monday, reporting that as a result of a strong trading performance in the final quarter, underpinned by an increase in the number of clients and an accelerated growth in product sales, its revenue and adjusted EBITDA for the year were expected to be around £13.4m and above £2.1m, respectively.
Read moreDiaceutics begins listed company life on AIM
21st Mar 2019 09:55
(Sharecast News) - Data analytics and implementation services company Diaceutics confirmed the admission of its entire issued ordinary share capital, which comprises 69,583,077 ordinary shares, to trading on AIM on Thursday morning.
Read more